Ardelyx Stock Today
| ARDX Stock | USD 5.47 0.05 0.92% |
PerformanceWeak
| Odds Of DistressLow
|
Ardelyx is trading at 5.47 as of the 16th of March 2025; that is 0.92 percent increase since the beginning of the trading day. The stock's open price was 5.42. Ardelyx has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of June 2014 | Category Healthcare | Classification Health Care |
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. The company has 238.36 M outstanding shares of which 27.9 M shares are presently shorted by private and institutional investors with about 8.35 trading days to cover. More on Ardelyx
Moving against Ardelyx Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Ardelyx Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Michael Raab | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Management, Management, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsArdelyx can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ardelyx's financial leverage. It provides some insight into what part of Ardelyx's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ardelyx (ARDX) is traded on NASDAQ Exchange in USA. It is located in 400 Fifth Avenue, Waltham, MA, United States, 02451 and employs 395 people. Ardelyx is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.3 B. Ardelyx conducts business under Biotechnology sector and is part of Health Care industry. The entity has 238.36 M outstanding shares of which 27.9 M shares are presently shorted by private and institutional investors with about 8.35 trading days to cover.
Ardelyx currently holds about 90.62 M in cash with (44.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Check Ardelyx Probability Of Bankruptcy
Ownership AllocationArdelyx holds a total of 238.36 Million outstanding shares. Over half of Ardelyx's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ardelyx Ownership Details
Ardelyx Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Goldman Sachs Group Inc | 2024-12-31 | 2.2 M | |
| Northern Trust Corp | 2024-12-31 | 2.2 M | |
| Oracle Investment Management Inc | 2024-12-31 | 2.1 M | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 2 M | |
| Bank Of America Corp | 2024-12-31 | 1.9 M | |
| Two Seas Capital Lp | 2024-12-31 | 1.9 M | |
| Rubric Capital Management Lp | 2024-12-31 | 1.7 M | |
| Redmile Group, Llc | 2024-12-31 | 1.6 M | |
| D. E. Shaw & Co Lp | 2024-12-31 | 1.5 M | |
| Hhg Plc | 2024-12-31 | 24.4 M | |
| Blackrock Inc | 2024-12-31 | 18.5 M |
Ardelyx Historical Income Statement
Ardelyx Stock Against Markets
Ardelyx Corporate Management
| Elizabeth Esq | Chief Secretary | Profile | |
| Susan Rodriguez | Chief Officer | Profile | |
| Joseph Reilly | Senior Officer | Profile | |
| CPA MST | CFO Treasurer | Profile | |
| Robert Felsch | Senior Officer | Profile |
Already Invested in Ardelyx?
The danger of trading Ardelyx is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ardelyx is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ardelyx. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ardelyx is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Ardelyx Stock Analysis
When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.